• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激肽释放酶基因簇中的拷贝数变异。

Copy number variants in the kallikrein gene cluster.

机构信息

Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Skåne University Hospital, Malmö, Sweden.

出版信息

PLoS One. 2013 Jul 22;8(7):e69097. doi: 10.1371/journal.pone.0069097. Print 2013.

DOI:10.1371/journal.pone.0069097
PMID:23894413
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3718828/
Abstract

The kallikrein gene family (KLK1-KLK15) is the largest contiguous group of protease genes within the human genome and is associated with both risk and outcome of cancer and other diseases. We searched for copy number variants in all KLK genes using quantitative PCR analysis and analysis of inheritance patterns of single nucleotide polymorphisms. Two deletions were identified: one 2235-bp deletion in KLK9 present in 1.2% of alleles, and one 3394-bp deletion in KLK15 present in 4.0% of alleles. Each deletion eliminated one complete exon and created out-of-frame coding that eliminated the catalytic triad of the resulting truncated gene product, which therefore likely is a non-functional protein. Deletion breakpoints identified by DNA sequencing located the KLK9 deletion breakpoint to a long interspersed element (LINE) repeated sequence, while the deletion in KLK15 is located in a single copy sequence. To search for an association between each deletion and risk of prostate cancer (PC), we analyzed a cohort of 667 biopsied men (266 PC cases and 401 men with no evidence of PC at biopsy) using short deletion-specific PCR assays. There was no association between evidence of PC in this cohort and the presence of either gene deletion. Haplotyping revealed a single origin of each deletion, with most recent common ancestor estimates of 3000-8000 and 6000-14 000 years for the deletions in KLK9 and KLK15, respectively. The presence of the deletions on the same haplotypes in 1000 Genomes data of both European and African populations indicate an early origin of both deletions. The old age in combination with homozygous presence of loss-of-function variants suggests that some kallikrein-related peptidases have non-essential functions.

摘要

激肽释放酶基因家族(KLK1-KLK15)是人类基因组中最大的连续蛋白酶基因群,与癌症和其他疾病的风险和结果都有关。我们使用定量 PCR 分析和单核苷酸多态性遗传模式分析,在所有 KLK 基因中搜索拷贝数变异。鉴定出两种缺失:一种是 KLK9 中的 2235 个碱基对缺失,存在于 1.2%的等位基因中,另一种是 KLK15 中的 3394 个碱基对缺失,存在于 4.0%的等位基因中。每个缺失消除了一个完整的外显子,并产生了无框架编码,消除了由此产生的截短基因产物的催化三联体,因此可能是一种无功能的蛋白质。通过 DNA 测序确定的缺失断点将 KLK9 缺失断点定位到长散在元件(LINE)重复序列,而 KLK15 的缺失位于单个拷贝序列中。为了研究每个缺失与前列腺癌(PC)风险之间的关联,我们使用短缺失特异性 PCR 检测分析了 667 例活检男性(266 例 PC 病例和 401 例活检无 PC 证据的男性)的队列。在该队列中,PC 的证据与两种基因缺失的存在均无关。单体型分析显示,每种缺失均来自单一起源,KLK9 和 KLK15 缺失的最近共同祖先估计分别为 3000-8000 和 6000-14000 年。1000 基因组数据中两种缺失在欧洲和非洲人群中的相同单体型上的存在表明,这两种缺失的起源都很早。这些缺失的古老年龄与功能丧失变异的纯合存在相结合,表明某些激肽释放酶相关肽酶具有非必需的功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd9d/3718828/60bb6a13db24/pone.0069097.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd9d/3718828/a3289c4c6230/pone.0069097.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd9d/3718828/f890d1271af3/pone.0069097.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd9d/3718828/60bb6a13db24/pone.0069097.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd9d/3718828/a3289c4c6230/pone.0069097.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd9d/3718828/f890d1271af3/pone.0069097.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd9d/3718828/60bb6a13db24/pone.0069097.g003.jpg

相似文献

1
Copy number variants in the kallikrein gene cluster.激肽释放酶基因簇中的拷贝数变异。
PLoS One. 2013 Jul 22;8(7):e69097. doi: 10.1371/journal.pone.0069097. Print 2013.
2
Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer.人组织激肽释放酶15基因(KLK15)的分子克隆。在前列腺癌中的上调。
J Biol Chem. 2001 Jan 5;276(1):53-61. doi: 10.1074/jbc.M005432200.
3
Intron retention: a common splicing event within the human kallikrein gene family.内含子保留:人类激肽释放酶基因家族中的一种常见剪接事件。
Clin Chem. 2005 Mar;51(3):506-15. doi: 10.1373/clinchem.2004.042341. Epub 2005 Jan 13.
4
Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data.澳大利亚前列腺素原(KLK15)遗传变异与前列腺癌风险和侵袭性的关联及 GWAS 数据的荟萃分析。
PLoS One. 2011;6(11):e26527. doi: 10.1371/journal.pone.0026527. Epub 2011 Nov 23.
5
A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33.对 19q13.33 染色体上 KLK15-KLK3-KLK2 基因座进行全面重测序分析。
Hum Genet. 2010 Jan;127(1):91-9. doi: 10.1007/s00439-009-0751-5. Epub 2009 Oct 13.
6
The canine kallikrein-related peptidases 9 and 10: structural characterization and expression in mammary cancer.犬类激肽释放酶相关肽酶 9 和 10:结构特征及在乳腺癌中的表达。
Mamm Genome. 2009 Nov-Dec;20(11-12):758-67. doi: 10.1007/s00335-009-9237-y. Epub 2009 Dec 2.
7
A completed KLK activome profile: investigation of activation profiles of KLK9, 10, and 15.完整的激肽释放酶激活组图谱:激肽释放酶9、10和15激活图谱的研究
Biol Chem. 2009 Apr;390(4):373-7. doi: 10.1515/BC.2009.026.
8
The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9).扩展的人激肽释放酶基因家族:基因座特征及新成员KLK-L3(KLK9)的分子克隆
Genomics. 2000 Apr 15;65(2):184-94. doi: 10.1006/geno.2000.6159.
9
MSR1 repeats modulate gene expression and affect risk of breast and prostate cancer.MSR1 重复序列可调节基因表达并影响乳腺癌和前列腺癌的风险。
Ann Oncol. 2018 May 1;29(5):1292-1303. doi: 10.1093/annonc/mdy082.
10
Localization of a new prostate-specific antigen-related serine protease gene, KLK4, is evidence for an expanded human kallikrein gene family cluster on chromosome 19q13.3-13.4.一种新的前列腺特异性抗原相关丝氨酸蛋白酶基因KLK4的定位,证明了人激肽释放酶基因家族在19号染色体q13.3 - 13.4区域的扩展。
J Biol Chem. 1999 Aug 13;274(33):23210-4. doi: 10.1074/jbc.274.33.23210.

本文引用的文献

1
Genetic polymorphisms in the human tissue kallikrein (KLK) locus and their implication in various malignant and non-malignant diseases.人类组织激肽释放酶(KLK)基因座的遗传多态性及其在各种恶性和非恶性疾病中的意义。
Biol Chem. 2012 Dec;393(12):1365-90. doi: 10.1515/hsz-2012-0211.
2
Phenotypic impact of genomic structural variation: insights from and for human disease.基因组结构变异的表型影响:来自人类疾病的见解和应用。
Nat Rev Genet. 2013 Feb;14(2):125-38. doi: 10.1038/nrg3373.
3
A systematic survey of loss-of-function variants in human protein-coding genes.
人类蛋白编码基因功能丧失变异的系统调查。
Science. 2012 Feb 17;335(6070):823-8. doi: 10.1126/science.1215040.
4
Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder.全基因组拷贝数变异研究将代谢型谷氨酸受体基因网络与注意缺陷多动障碍相关联。
Nat Genet. 2011 Dec 4;44(1):78-84. doi: 10.1038/ng.1013.
5
Genome structural variation discovery and genotyping.基因组结构变异发现与基因分型。
Nat Rev Genet. 2011 May;12(5):363-76. doi: 10.1038/nrg2958. Epub 2011 Mar 1.
6
A map of human genome variation from population-scale sequencing.人类基因组变异的图谱来自于基于人群的测序。
Nature. 2010 Oct 28;467(7319):1061-73. doi: 10.1038/nature09534.
7
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.60 岁时前列腺特异性抗原浓度与前列腺癌死亡或转移的关系:病例对照研究。
BMJ. 2010 Sep 14;341:c4521. doi: 10.1136/bmj.c4521.
8
Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.血液生物标志物水平有助于发现与癌症相关的单核苷酸多态性:激肽释放酶与前列腺癌。
Cancer Prev Res (Phila). 2010 May;3(5):611-9. doi: 10.1158/1940-6207.CAPR-09-0206. Epub 2010 Apr 27.
9
Mutation spectrum revealed by breakpoint sequencing of human germline CNVs.人类种系 CNV 断点测序揭示的突变谱。
Nat Genet. 2010 May;42(5):385-91. doi: 10.1038/ng.564. Epub 2010 Apr 4.
10
Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls.全基因组关联研究分析了 16000 例 8 种常见疾病和 3000 例共享对照的 CNVs。
Nature. 2010 Apr 1;464(7289):713-20. doi: 10.1038/nature08979.